Display options
Cite
Milam P, Berger M, Ramaswamy B, et al. Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine. J Clin Aesthet Dermatol. 2019;12(7):23-26
Milam, P., Berger, M., Ramaswamy, B., Reinbolt, R., Wesolowski, R., & Kaffenberger, B. H. (2019). Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine. The Journal of clinical and aesthetic dermatology, 12(7), 23-26.
Milam, Philip, et al. "Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine." The Journal of clinical and aesthetic dermatology vol. 12,7 (2019): 23-26.
Milam P, Berger M, Ramaswamy B, Reinbolt R, Wesolowski R, Kaffenberger BH. Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine. J Clin Aesthet Dermatol. 2019 Jul;12(7):23-26. Epub 2019 Jul 01. PMID: 31531159; PMCID: PMC6715332.
Copy Download .nbib Format: NLM
Share it on

J Clin Aesthet Dermatol. 2019 Jul;12(7):23-26. Epub 2019 Jul 01.

Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine.

The Journal of clinical and aesthetic dermatology

Philip Milam, Michael Berger, Bhuvaneswari Ramaswamy, Raquel Reinbolt, Robert Wesolowski, Benjamin H Kaffenberger

Affiliations

  1. Drs. Milam and Kaffenberger are with the Division of Dermatology at The Ohio State University Wexner Medical Center in Columbus, Ohio.
  2. Drs. Berger, Ramaswamy, Reinbolt, and Weslowski are with the Division of Medical Oncology at The Ohio State University Comprehensive Cancer Center in Columbus, Ohio.

PMID: 31531159 PMCID: PMC6715332

[No abstract available.]

Keywords: Ado-trastuzumab emtansine; T-DM1; cirrhosis; metastatic breast cancer; nodular regenerative hyperplasia; palmar flushing; pseudocirrhosis; telangiectasia

Conflict of interest statement

FUNDING:No funding was provided for this study. DISCLOSURES:The authors report no conflicts of interest relevant to the content of this article.

References

  1. Am J Gastroenterol. 1999 Feb;94(2):502-7 - PubMed
  2. World J Gastroenterol. 2003 Dec;9(12):2832-5 - PubMed
  3. Gastroenterology. 2008 Apr;134(4):960-74 - PubMed
  4. Rheumatology (Oxford). 2009 May;48(5):569-72 - PubMed
  5. Lancet Oncol. 2009 Jun;10(6):615-21 - PubMed
  6. Clin Dermatol. 2010 Jul-Aug;28(4):391-9 - PubMed
  7. Clin Cancer Res. 2011 Oct 15;17(20):6437-47 - PubMed
  8. Hepatology. 2012 Jul;56(1):239-47 - PubMed
  9. Radiol Med. 2013 Feb;118(1):1-13 - PubMed
  10. N Engl J Med. 2012 Nov 8;367(19):1783-91 - PubMed
  11. Ann Hepatol. 2013 Sep-Oct;12(5):834-6 - PubMed
  12. Hepatology. 2014 Jun;59(6):2419-21 - PubMed
  13. Lancet Oncol. 2014 Jun;15(7):689-99 - PubMed
  14. Breast Cancer Res Treat. 2014 Jul;146(2):451-6 - PubMed
  15. J Clin Oncol. 2014 Sep 1;32(25):2750-7 - PubMed
  16. Ann Oncol. 2015 Feb;26(2):436-7 - PubMed
  17. Int J Dermatol. 2015 Jul;54(7):752-6 - PubMed
  18. Mol Cancer Ther. 2016 Mar;15(3):480-90 - PubMed
  19. Chest. 2016 Apr;149(4):e103-5 - PubMed
  20. J Clin Immunol. 2016 Nov;36(8):739-742 - PubMed
  21. Case Rep Gastroenterol. 2016 Jul 29;10(2):381-391 - PubMed

Publication Types